Here are phase II results for Winlevi. Note 37.2% efficacy in reducing lesions after 8 week trial, compared to BTX 1503 efficacy of 47% after 4 week trial
Ann: Trading Halt, page-120
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 147750 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 632850 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |